Insmed Inc (INSM)vsOS Therapies Incorporated (OSTX)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
OSTX
OS Therapies Incorporated
$1.44
+4.35%
HEALTHCARE · Cap: $53.53M
Smart Verdict
WallStSmart Research — data-driven comparison
OSTX leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
OSTX
Avoid16
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Trading at 13.1x book value
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : OSTX
OSTX has a balanced fundamental profile.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : OSTX
The primary concerns for OSTX are Price/Book, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while OSTX is a value play — different risk/reward profiles.
INSM is growing revenue faster at 1.5% — sustainability is the question.
OSTX generates stronger free cash flow (-5M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
INSM scores higher overall (39/100 vs 16/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
OS Therapies Incorporated
HEALTHCARE · BIOTECHNOLOGY · USA
OS Therapies Incorporated is a biopharmaceutical innovator focused on developing groundbreaking treatments for patients with unmet medical needs, particularly in the neurological disorder space. The company has a robust pipeline powered by its proprietary drug development technologies, which aim to enhance patient outcomes and overall quality of life. With a steadfast commitment to research excellence and a strategic emphasis on high-impact therapeutic areas, OS Therapies represents a compelling investment opportunity for institutional investors seeking to engage in the dynamic and evolving biotech sector.
Visit Website →Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?